Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Accumulated Expenses (2020 - 2025)

Celularity has reported Accumulated Expenses over the past 6 years, most recently at $29.4 million for Q3 2025.

  • Quarterly results put Accumulated Expenses at $29.4 million for Q3 2025, up 103.38% from a year ago — trailing twelve months through Sep 2025 was $29.4 million (up 103.38% YoY), and the annual figure for FY2024 was $19.8 million, up 161.77%.
  • Accumulated Expenses for Q3 2025 was $29.4 million at Celularity, down from $33.4 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CELU hit a ceiling of $33.4 million in Q2 2025 and a floor of $7.6 million in Q4 2023.
  • Median Accumulated Expenses over the past 5 years was $13.4 million (2022), compared with a mean of $15.8 million.
  • Biggest five-year swings in Accumulated Expenses: tumbled 54.1% in 2023 and later skyrocketed 221.35% in 2025.
  • Celularity's Accumulated Expenses stood at $11.7 million in 2021, then fell by 22.23% to $9.1 million in 2022, then dropped by 16.42% to $7.6 million in 2023, then surged by 161.77% to $19.8 million in 2024, then surged by 48.28% to $29.4 million in 2025.
  • The last three reported values for Accumulated Expenses were $29.4 million (Q3 2025), $33.4 million (Q2 2025), and $25.2 million (Q1 2025) per Business Quant data.